Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2021 ∙ Knuf, M. Haas, H. Garcia-Corbeira, P. Turriani, E. Mukherjee, P. Janssens, W. Berlaimont, V.
Hexavalent vaccines: What can we learn from head-to-head studies?
All age groups Diphtheria Tetanus Pertussis Hepatitis B Poliomyelitis Haemophilus influenzae type B Efficacy/effectiveness Safety Administration
Rating:
Critically low
2021 ∙ Parsons, J. Griffiths, S. E. Thomas, N. Atherton, H.
How effective are digital interventions in increasing flu vaccination among pregnant women? A systematic review and meta-analysis
Pregnant women All age groups Influenza Coverage Acceptance
Rating:
Not applicable
2021 ∙ Poirier, B. Sethi, S. Garvey, G. Hedges, J. Canfell, K. Smith, M. Ju, X. Jamieson, L.
HPV vaccine: uptake and understanding among global Indigenous communities - a qualitative systematic review
All age groups Human papillomavirus (HPV) Acceptance Coverage
Rating:
Not applicable
2021 ∙ Dorji, T. Nopsopon, T. Tamang, S. T. Pongpirul, K.
Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis
All age groups Low and Middle Income Countries Human papillomavirus (HPV) Coverage
Rating:
Not applicable
2021 ∙ Tian, Y. Hua, W. Wu, Y. Zhang, T. Wang, W. Wu, H. Guo, C. Huang, X.
Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis
Adults Older adults Hepatitis B Administration Efficacy/effectiveness
Rating:
Critically low
2021 ∙ Bianchi, F. P. Stefanizzi, P. Spinelli, G. Mascipinto, S. Tafuri, S.
Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis
All age groups Acceptance Coverage
Rating:
Not applicable
2021 ∙ Martin, C. Domingo, C. Bottieau, E. Buonfrate, D. De Wit, S. Van Laethem, Y. Dauby, N.
Immunogenicity and duration of protection after yellow fever vaccine in people living with human immunodeficiency virus: a systematic review
All age groups Yellow fever Efficacy/effectiveness
Rating:
Critically low
2021 ∙ Schenk, J. Abrams, S. Theeten, H. Van Damme, P. Beutels, P. Hens, N.
Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis
All age groups Mumps Measles Rubella Efficacy/effectiveness Coverage Administration Modeling
Rating:
Critically low
2021 ∙ Becerril-Gaitan, Andrea Vaca-Cartagena, Bryan F. Ferrigno, Ana S. Mesa-Chavez, Fernanda Barrientos-Gutiérrez, Tonatiuh Tagliamento, Marco Lambertini, Matteo Villarreal-Garza, Cynthia
Immunogenicity and Risk of SARS-CoV-2 Infection after COVID-19 Vaccination in Patients with Cancer: A Systematic Review and Meta-Analysis
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2021 ∙ Liang, Y. Jing-Xia, G. Ma, L. Ni, L. Chaolie, R. Zhou, J. Guo-Yang, L.
Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis
Adults Influenza Efficacy/effectiveness Safety Administration
Rating:
Critically low
Loading...